文献速递头颈外科咽喉与嗓音

选择性颈清扫改善T3cN0M0声门型鳞状细胞癌生存

Improving Survival of T3cN0M0 Glottic Squamous Cell Cancer With Elective Neck Dissection.
PubMed 文献 · Laryngoscope · 2021-12-07

基于SEER数据库2004至2015年1589例T3cN0M0声门型鳞状细胞癌患者的回顾性人群分析,经倾向评分匹配后,选择性颈清扫组的总生存(中位生存93个月 vs 55个月,P=0.0047)和癌症特异性生存(HR 0.48,95%CI 0.29-0.77,P=0.003)均优于非选择性颈清扫组。

要点

  • T3cN0M0声门型鳞癌中仅22%至58%接受了选择性颈清扫。
  • 匹配后选择性颈清扫组中位总生存93个月,非选择性颈清扫组55个月。
  • 选择性颈清扫与更好的癌症特异性生存相关(HR 0.48)。

核心结论

  • 在T3cN0M0声门型鳞状细胞癌患者中,选择性颈清扫与更好的生存结局显著相关。

研究设计与样本

  • 回顾性人群数据库分析,提取SEER数据库2004至2015年T3cN0M0声门型鳞状细胞癌患者1589例,分为选择性颈清扫组和非选择性颈清扫组,采用倾向评分匹配消除基线差异。

主要发现

  • 仅22%至58%的T3cN0M0声门型鳞状细胞癌患者接受了选择性颈清扫。
  • 倾向评分匹配后,选择性颈清扫组中位总生存93个月 vs 非选择性颈清扫组55个月(P=0.0047)。
  • 倾向评分匹配后,选择性颈清扫组的癌症特异性生存优于非选择性颈清扫组(HR 0.48,95%CI 0.29-0.77,P=0.003)。
  • 亚组分析也提示选择性颈清扫组的总生存或癌症特异性生存优于非选择性颈清扫组。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES/HYPOTHESIS: This study aimed to elucidate the role of elective neck dissection (END) in improving the outcome of T3cN0M0 glottic squamous cell cancer (GSCC). STUDY DESIGN: Retrospective population-based database analysis. METHODS: Patients with T3cN0M0 GSCC in the Surveillance, Epidemiology, and End Results database (SEER) were extracted and stratified into END and non-END cohorts. Propensity score matching (PSM) was used to eliminate the baseline variations. The Kaplan-Meier method was performed to access the association between END and survival. RESULTS: We retrospectively analyzed 1,589 T3cN0M0 GSCC patients in the SEER database from 2004 to 2015, and found that only 22% to 58% T3cN0M0 GSCC were performed with END. After PSM, END cohort had better overall survival (OS) (median survival time: 93 vs. 55 months, respectively; P = .0047) and cancer-specific survival (CSS) (hazard ratio [HR] 0.48, 95% confidence interval [CI] 0.29-0.77, P = .003) than non-END cohort. In addition, Subgroup analysis also indicated END cohort had better OS or CSS than non-END cohort. CONCLUSION: This study demonstrated that in patients with T3cN0M0 GSCC, END significantly associated with better survival outcomes compared with non-END. LEVEL OF EVIDENCE: 3 Laryngoscope, 132:1807-1816, 2022.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Cai Z, Chen L, Zhang J, et al. Improving Survival of T3cN0M0 Glottic Squamous Cell Cancer With Elective Neck Dissection. Laryngoscope. 2021. PMID: 34873700. doi:10.1002/lary.29973

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。